Sunday, August 19, 2018

Jubilant Life Sciences plans Rs 550-cr capex in FY19

Jubilant Life Sciences plans Rs 550-cr capex in FY19 It is also planning to invest Rs 300 crore in research and development (RD) in FY19.

from Moneycontrol Business News https://ift.tt/2MvepVp

No comments:

Post a Comment

Bitcoin stays near $64K, Ethereum underperforms as weak risk appetite keeps crypto markets under pressure

Bitcoin traded near $64,000 and Ethereum underperformed as risk appetite weakened. The global crypto market capitalization edged down 2% to ...